Sandra Martínez-Morilla

946 total citations
24 papers, 541 citations indexed

About

Sandra Martínez-Morilla is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra Martínez-Morilla has authored 24 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra Martínez-Morilla's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (6 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Sandra Martínez-Morilla is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (6 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Sandra Martínez-Morilla collaborates with scholars based in United States, Sweden and Greece. Sandra Martínez-Morilla's co-authors include David L. Rimm, Yalai Bai, Jon Zugazagoitia, Balázs Ács, Vesal Yaghoobi, Maria Toki, Vasiliki Pelekanou, Myrto Moutafi, Thazin Nwe Aung and Samuel Leung and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sandra Martínez-Morilla

24 papers receiving 535 citations

Peers

Countries citing papers authored by Sandra Martínez-Morilla

Since Specialization

Citations

This map shows the geographic impact of Sandra Martínez-Morilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Martínez-Morilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Martínez-Morilla more than expected).

Fields of papers citing papers by Sandra Martínez-Morilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Martínez-Morilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Martínez-Morilla. The network helps show where Sandra Martínez-Morilla may publish in the future.

Co-authorship network of co-authors of Sandra Martínez-Morilla

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Martínez-Morilla. A scholar is included among the top collaborators of Sandra Martínez-Morilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Martínez-Morilla. Sandra Martínez-Morilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma 2024 ·Clinical Cancer Research ·Thazin Nwe Aung, Jonathan Warrell, Sandra Martínez-Morilla, Niki Gavrielatou, (unknown), Vesal Yaghoobi, Harriet M. Kluger, Mark Gerstein, David L. Rimm	6
2	Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma 2023 ·Clinical Cancer Research ·(unknown), Daniel Y. Lee, (unknown), Sandra Martínez-Morilla, Thazin Nwe Aung, (unknown), Xueting Wang, Wei Wei, William Damsky, Mario Sznol, Harriet M. Kluger, David L. Rimm, Jeffrey J. Ishizuka	3
3	Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy 2023 ·OncoImmunology ·Sandra Martínez-Morilla, Myrto Moutafi, Aileen I. Fernandez, Shlomit Jessel, Prajan Divakar, Pok Fai Wong, Rolando García-Milian, Kurt A. Schalper, Harriet M. Kluger, David L. Rimm	5
4	Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling 2022 ·Journal of Thoracic Oncology ·Myrto Moutafi, Sandra Martínez-Morilla, Prajan Divakar, (unknown), Niki Gavrielatou, Thazin Nwe Aung, Vesal Yaghoobi, Aileen I. Fernandez, Jon Zugazagoitia, Roy S. Herbst, Kurt A. Schalper, David L. Rimm	23
5	Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC 2022 ·Journal of Thoracic Oncology ·Aileen I. Fernandez, Niki Gavrielatou, (unknown), Saba Shafi, Myrto Moutafi, Sandra Martínez-Morilla, (unknown), Thazin Nwe Aung, Vesal Yaghoobi, Yalai Bai, Yvonne G. Y. Chan, Jodi Weidler, Roy S. Herbst, Michael Bates, David L. Rimm	8
6	Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade 2022 ·npj Precision Oncology ·Ioannis Vathiotis, Leonidas Salichos, Sandra Martínez-Morilla, Niki Gavrielatou, Thazin Nwe Aung, Saba Shafi, Pok Fai Wong, Shlomit Jessel, Harriet M. Kluger, Konstantinos N. Syrigos, Sarah Warren, Mark Gerstein, David L. Rimm	5
7	An In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine Erythropoiesis 2022 ·Experimental Hematology ·(unknown), Sandra Martínez-Morilla, Srividhya Venkatesan, (unknown), (unknown), Dirk Görlich, Shilpa M. Hattangadi, Gary M. Kupfer	3
8	Not all well-differentiated cutaneous squamous cell carcinomas are equal: Tumors with disparate biologic behavior have differences in protein expression via digital spatial profiling 2022 ·Journal of the American Academy of Dermatology ·Matthew D. Vesely, Sandra Martínez-Morilla, Jeff Gehlhausen, Jennifer M. McNiff, Peter G. Whang, David L. Rimm, Christine J. Ko	7
9	Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms 2022 ·EBioMedicine ·Thazin Nwe Aung, Saba Shafi, James S. Wilmott, Saeed Nourmohammadi, Ioannis Vathiotis, Niki Gavrielatou, Aileen I. Fernandez, Vesal Yaghoobi, Tobias Sinnberg, Teresa Amaral, Kristian Ikenberg, Kiarash Khosrotehrani, Iman Osman, Balázs Ács, Yalai Bai, Sandra Martínez-Morilla, Myrto Moutafi, John F. Thompson, Richard A. Scolyer, David L. Rimm	25
10	Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer 2022 ·Laboratory Investigation ·Myrto Moutafi, Charles T. Robbins, Vesal Yaghoobi, Aileen I. Fernandez, Sandra Martínez-Morilla, (unknown), Yalai Bai, Yan Song, Patricia Gaule, Joseph S. Krueger, K. Bloom, (unknown), D.C. Liebler, Regan Fulton, David L. Rimm	91
11	An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer 2021 ·Clinical Cancer Research ·Yalai Bai, Kimberly Cole, Sandra Martínez-Morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Niméus, Johan Hartman, Balázs Ács, David L. Rimm	38
12	Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry 2021 ·Clinical Cancer Research ·Sandra Martínez-Morilla, Franz Villarroel‐Espíndola, Pok Fai Wong, Maria Toki, Thazin Nwe Aung, Vasiliki Pelekanou, (unknown), Kurt A. Schalper, Harriet M. Kluger, David L. Rimm	42
13	A new tool for technical standardization of the Ki67 immunohistochemical assay 2021 ·Modern Pathology ·Thazin Nwe Aung, Balázs Ács, Jonathan Warrell, Yalai Bai, Patricia Gaule, Sandra Martínez-Morilla, (unknown), Saba Shafi, Myrto Moutafi, Mark Gerstein, (unknown), Regan Fulton, David L. Rimm	34
14	240 Discovery of biomarkers of resistance to immune checkpoint blockade in non-small-cell lung cancer (NSCLC) using high-plex digital spatial profiling 2021 ·Regular and Young Investigator Award Abstracts ·Myrto Moutafi, Sandra Martínez-Morilla, Prajan Divakar, Ioannis Vathiotis, Niki Gavrielatou, Thazin Nwe Aung, Vesal Yaghoobi, Aileen I. Fernandez, (unknown), Kurt A. Schalper, David L. Rimm	1
15	Association between low estrogen receptor positive breast cancer and staining performance 2020 ·npj Breast Cancer ·Dennis L. Caruana, Wei Wei, Sandra Martínez-Morilla, David L. Rimm, Emily Reisenbichler	22
16	Digital quantitative assessment of PD-L1 using digital spatial profiling 2020 ·Laboratory Investigation ·Swati Gupta, Jon Zugazagoitia, Sandra Martínez-Morilla, Kit Fuhrman, David L. Rimm	23
17	Antibody Validation for Protein Expression on Tissue Slides: A Protocol for Immunohistochemistry 2020 ·BioTechniques ·(unknown), (unknown), Sandra Martínez-Morilla, Vesal Yaghoobi, Jon Zugazagoitia, Yuting Liu, David L. Rimm	32
18	Abstract 2001: Biomarker discovery in immunotherapy-treated melanoma patients with imaging mass cytometry 2020 ·Cancer Research ·Sandra Martínez-Morilla, Franz Villarroel‐Espíndola, Pok Fai Wong, Harriet M. Kluger, Maria Toki, (unknown), Vasiliki Pelekanou, (unknown), David L. Rimm	1
19	Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy 2020 ·OncoImmunology ·Sandra Martínez-Morilla, Jon Zugazagoitia, Pok Fai Wong, Harriet M. Kluger, David L. Rimm	21
20	Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study 2018 ·Laboratory Investigation ·Balázs Ács, Vasiliki Pelekanou, Yalai Bai, Sandra Martínez-Morilla, Maria Toki, Samuel Leung, Torsten O. Nielsen, David L. Rimm	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact